Phio Pharmaceuticals Corp... (PHIO)
NASDAQ: PHIO
· Real-Time Price · USD
1.90
0.09 (4.97%)
At close: May 13, 2025, 3:59 PM
1.86
-1.85%
After-hours: May 13, 2025, 07:55 PM EDT
4.97% (1D)
| Bid | 1.86 |
| Market Cap | 9.05M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.15M |
| EPS (ttm) | -9.08 |
| PE Ratio (ttm) | -0.21 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 1.92 |
| Volume | 1,648,249 |
| Avg. Volume (20D) | 3,172,122 |
| Open | 1.75 |
| Previous Close | 1.81 |
| Day's Range | 1.75 - 2.10 |
| 52-Week Range | 0.97 - 9.79 |
| Beta | 0.98 |
About PHIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PHIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PHIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+18.6%
Phio Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
1 month ago
+52.48%
Phio Pharmaceuticals shares are trading higher after the company announced its Safety Monitoring Committee recommended dose escalation in the Phase 1b trial of PH-762.
